An Act to amend the Controlled Drugs and Substances Act (production of or trafficking in substances)

Sponsor

Bob Saroya  Conservative

Introduced as a private member’s bill. (These don’t often become law.)

Status

Second reading (House), as of Dec. 6, 2016

Subscribe to a feed (what's a feed?) of speeches and votes in the House related to Bill C-324.

Summary

This is from the published bill. The Library of Parliament often publishes better independent summaries.

This enactment amends the Controlled Drugs and Substances Act in order to prohibit the possession, production, sale or importation of anything if it is known that it will be used in the production or traffic of certain substances included in Schedule I to that Act.

Elsewhere

All sorts of information on this bill is available at LEGISinfo, provided by the Library of Parliament. You can also read the full text of the bill.

March 20th, 2017 / 1:30 p.m.
See context

Liberal

Arnold Chan Liberal Scarborough—Agincourt, ON

I'll just quickly comment and thank the analyst for his comments.

On Mr. Saroya's bill, the government would agree that there are no constitutional or jurisdictional issues. It's very similar to his previous Bill C-324 in the sense that it's an act that proposes to amend the Controlled Drugs and Substances Act, but it deals with different sections than Bill C-37, which is currently before the House. We would agree that there are no constitutional or jurisdictional issues.

On the Senate bill sponsored by Mr. Carignan, Bill S-230, an act to amend the Criminal Code regarding drug-impaired driving, I believe there is a similar bill before the House, Bill C-226, but the bills deal with substantively different frameworks and issues. Therefore, from the perspective of the government, it does not meet the criterion regarding a similar piece of legislation before the House, which was set out by a ruling from Speaker Fraser. From our perspective, the bills are not substantively the same; therefore, the matter is constitutional and votable.

Procedure and House AffairsCommittees of the HouseRoutine Proceedings

February 8th, 2017 / 3:10 p.m.
See context

Liberal

Larry Bagnell Liberal Yukon, YT

Mr. Speaker, I have the honour to present, in both official languages, the 21st report of the Standing Committee on Procedure and House Affairs. The committee advises that, pursuant to Standing Order 92(3)(a), the committee reports that it has concurred in the report of the Subcommittee on Private Members' Business arising that Bill C-324, An Act to amend the Controlled Drugs and Substances Act (production of or trafficking in substances) should be designated non-votable.

February 2nd, 2017 / 1:25 p.m.
See context

Committee Researcher

Alexandre Lavoie

Right, it's the exact same section. It's really just the scope of it. The government would include all of the scheduled substances, whereas Bill C-324 would only add a few substances to the prohibition.

Controlled Drugs and Substances ActRoutine Proceedings

December 1st, 2016 / 10:10 a.m.
See context

Conservative

Bob Saroya Conservative Markham—Unionville, ON

moved for leave to introduce Bill C-324, An Act to amend the Controlled Drugs and Substances Act (production of or trafficking in substances).

Mr. Speaker, I am honoured to introduce a bill that would amend the Controlled Drugs and Substances Act to prohibit the possession, production, sale, or importation of anything if it is known to be used in the production or trafficking of certain substances included in schedule I of the act.

These substances would include methamphetamines, ecstasy, fentanyl, and W-18. These substances are a deadly scourge in our communities, which are now plagued by a full-blown epidemic of fentanyl overdoses. Those that traffic and produce these substances must face the long arm of the law.

I will always work to ensure the health and safety of all Canadians, especially my constituents in Markham—Unionville. I hope all members of the House will support this bill.

(Motions deemed adopted, bill read the first time and printed)